| Primary Cutaneous CD30 Positive T-Cell Lymphoproliferative Disorders studied in …STUDIED_INderived13 of 13show fewer |
|---|
| → studied in | NCT03409432Phase 2 · completed Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | Lymphomatoid Papulosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07717580Phase 2 · not yet recruiting Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL) · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | Primary Cutaneous Anaplastic Large Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01352520Phase 2 · active not recruiting SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | Primary Cutaneous Anaplastic Large Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06207812recruiting Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | Lymphomatoid Papulosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01787409NA · active not recruiting Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | Primary Cutaneous Anaplastic Large Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03602157Phase 1 · active not recruiting Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | Lymphomatoid Papulosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05978141recruiting A Registry for People With T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | Primary Cutaneous Anaplastic Large Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03587844Phase 2 · recruiting Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | Lymphomatoid Papulosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02840747recruiting Tissue Repository: CTCL Collection Protocol · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | Lymphomatoid Papulosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05106192NA · withdrawn Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | Lymphomatoid Papulosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01578499Phase 3 · completed A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | Primary Cutaneous Anaplastic Large Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01134341Phase 1 · completed Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | Primary Cutaneous Anaplastic Large Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02652715NA · completed Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | Primary Cutaneous Anaplastic Large Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |